MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
31 Outubro 2023 - 5:30PM
MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
focused on developing, manufacturing and commercializing innovative
antibody-based therapeutics for the treatment of cancer, today
announced that the Company will release its financial results for
the third quarter of 2023 after the market closes on Monday,
November 6, 2023. MacroGenics will host a conference call to
discuss the financial results and recent corporate progress on
Monday, November 6, 2023, at 4:30 pm ET.
Conference Call Information
To participate via telephone, please register in advance at this
link. Upon registration, all telephone participants will receive a
confirmation email detailing how to join the conference call,
including the dial-in number along with a unique passcode and
registrant ID that can be used to access the call. The listen-only
webcast of the conference call can be accessed under "Events &
Presentations" in the Investor Relations section of the Company's
website at http://ir.macrogenics.com/events.cfm. A recorded replay
of the webcast will be available shortly after the conclusion of
the call and archived on the Company's website for 30 days
following the call.
About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused
on developing, manufacturing and commercializing innovative
monoclonal antibody-based therapeutics for the treatment of cancer.
The Company generates its pipeline of product candidates primarily
from its proprietary suite of next-generation antibody-based
technology platforms, which have applicability across broad
therapeutic domains. The combination of MacroGenics' technology
platforms and protein engineering expertise has allowed the Company
to generate promising product candidates and enter into several
strategic collaborations with global pharmaceutical and
biotechnology companies. For more information, please see the
Company's website at www.macrogenics.com. MacroGenics and the
MacroGenics logo are trademarks or registered trademarks of
MacroGenics, Inc.
###
CONTACTS:
Jim Karrels, Senior Vice President, CFO
1-301-251-5172, info@macrogenics.com
MacroGenics (NASDAQ:MGNX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
MacroGenics (NASDAQ:MGNX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024